Structure of the Bone Morphogenetic Protein Receptor ALK2 and Implications for Fibrodysplasia Ossificans Progressiva
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure of the Bone Morphogenetic Protein Receptor ALK2 and Implications for Fibrodysplasia Ossificans Progressiva
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 44, Pages 36990-36998
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2012-09-13
DOI
10.1074/jbc.m112.365932
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Promiscuity and specificity in BMP receptor activation
- (2012) Thomas D. Mueller et al. FEBS LETTERS
- A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H
- (2011) Satoshi Ohte et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- In vitro Analyses of the Dysregulated R206H ALK2 Kinase-FKBP12 Interaction Associated with Heterotopic Ossification in FOP
- (2011) Jay C. Groppe et al. CELLS TISSUES ORGANS
- Hyperactive BMP signaling induced by ALK2R206Hrequires type II receptor function in aDrosophilamodel for classic fibrodysplasia ossificans progressiva
- (2011) Viet Q. Le et al. DEVELOPMENTAL DYNAMICS
- Fibrodysplasia ossificans progressiva: Middle-age onset of heterotopic ossification from a unique missense mutation (c.974G > C, p.G325A) inACVR1
- (2011) Michael P Whyte et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date
- (2010) Celia L. Gregson et al. BONE
- Molecular Consequences of the ACVR1R206HMutation of Fibrodysplasia Ossificans Progressiva
- (2010) Gin-Ah Song et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Conversion of vascular endothelial cells into multipotent stem-like cells
- (2010) Damian Medici et al. NATURE MEDICINE
- Inherited human diseases of heterotopic bone formation
- (2010) Eileen M. Shore et al. Nature Reviews Rheumatology
- Applications of small molecule BMP inhibitors in physiology and disease
- (2009) Charles C. Hong et al. CYTOKINE & GROWTH FACTOR REVIEWS
- TGF-β Superfamily Signaling in Embryonic Development and Homeostasis
- (2009) Mary Y. Wu et al. DEVELOPMENTAL CELL
- Novel Mutations in ACVR1 Result in Atypical Features in Two Fibrodysplasia Ossificans Progressiva Patients
- (2009) Kirsten A. Petrie et al. PLoS One
- Structure and functional characterization of the atypical human kinase haspin
- (2009) J. Eswaran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A unique case of fibrodysplasia ossificans progressiva with anACVR1 mutation, G356D, other than the common mutation (R206H)
- (2008) Hirokazu Furuya et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor
- (2008) Toru Fukuda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements
- (2008) Renata Bocciardi et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1
- (2008) Frederick S. Kaplan et al. HUMAN MUTATION
- BMP-2/4 and BMP-6/7 Differentially Utilize Cell Surface Receptors to Induce Osteoblastic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells
- (2008) Karen Lavery et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Constitutively Activated ALK2 and Increased SMAD1/5 Cooperatively Induce Bone Morphogenetic Protein Signaling in Fibrodysplasia Ossificans Progressiva
- (2008) Toru Fukuda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BMP type I receptor inhibition reduces heterotopic ossification
- (2008) Paul B Yu et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More